{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:39:44Z","timestamp":1784205584934,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10815-020-01774-x","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T22:02:30Z","timestamp":1588802550000},"page":"1313-1322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["An explanation of the mechanisms underlying fragile X-associated premature ovarian insufficiency"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-8770","authenticated-orcid":false,"given":"Bruce I.","family":"Rose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"key":"1774_CR1","doi-asserted-by":"crossref","unstructured":"Dean DD, Muthuswamy S, Agarwal S. Fragile X syndrome: current insight. Egypt J Med Hum Genet. 2016;17:303\u20139.","DOI":"10.1016\/j.ejmhg.2016.01.005"},{"key":"1774_CR2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neuron.2017.01.001","volume":"93","author":"FB Gao","year":"2017","unstructured":"Gao FB, Richter JD. Microsatellite expansion diseases: repeat toxicity found in translation. Neuron. 2017;93:249\u201351.","journal-title":"Neuron"},{"key":"1774_CR3","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jmb.2018.12.012","volume":"432","author":"A Neueder","year":"2019","unstructured":"Neueder A. RNA-mediated disease mechanisms in neurodegenerative disorders. J Mol Biol. 2019;432:1780\u201391.","journal-title":"J Mol Biol"},{"issue":"1","key":"1774_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/brainsci9010017","volume":"9","author":"CM Yrigollen","year":"2019","unstructured":"Yrigollen CM, Davidson BL. CRISPR to the rescue: advances in gene editing for FMR1 gene. Brain Sci. 2019;9(1):17.","journal-title":"Brain Sci"},{"key":"1774_CR5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fncel.2017.00128","volume":"11","author":"HE Kong","year":"2017","unstructured":"Kong HE, Zhao J, Jin P, Jin Y. Fragile X-associated tremor\/ataxia syndrome: from molecular pathogenesis to development of therapeutics. Front Cell Neurosci. 2017;11:128.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1774_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2000-13476","volume":"18","author":"A Murray","year":"2000","unstructured":"Murray A. Premature Ovarian Failure and the FMR1 gene. Semin Reprod Med. 2000;18(1):59\u201366.","journal-title":"Semin Reprod Med"},{"key":"1774_CR7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/367713","volume":"72","author":"SL Nolan","year":"2003","unstructured":"Nolan SL, Brown WT, Glicksman A, Houck GE, Gargano A, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet. 2003;72:454\u201364.","journal-title":"Am J Hum Genet"},{"key":"1774_CR8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/ejhg.2009.51","volume":"17","author":"L Rodriguez-Revenga","year":"2009","unstructured":"Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, Xuncia M, Badenas C, et al. Penetrance of FMR1 premutation associated pathologies in fragile X families. Eur J Hum Genet. 2009;17:1359\u201362.","journal-title":"Eur J Hum Genet"},{"issue":"14","key":"1774_CR9","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/mds.21493","volume":"22","author":"E Berry-Kravis","year":"2017","unstructured":"Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, et al. Fragile X-associated tremor\/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord. 2017;22(14):2018\u201330.","journal-title":"Mov Disord"},{"key":"1774_CR10","first-page":"862","volume":"2","author":"RAM Buijsen","year":"2014","unstructured":"Buijsen RAM, Sellier C, Severijnen LAWFM, Oulad-Abdelghani M, Verhagen RFM, et al. FMRpolyG-positive inclusions in CNS and non-CNS organs of a fragile X premutation carrier with fragile X-associated tremor\/ataxia syndrome. Acta Neuropathol Commun. 2014;2:862\u20136.","journal-title":"Acta Neuropathol Commun"},{"key":"1774_CR11","doi-asserted-by":"crossref","unstructured":"Sellier C, Buijsen RAM, He F, Natia S, Jung L, et al. Translation of expanded CGG repeats into FMRpolyG is pathogenic and may contribute to fragile X tremor ataxia syndrome. Neuron. 2017;93:331\u201347.","DOI":"10.1016\/j.neuron.2016.12.016"},{"key":"1774_CR12","first-page":"43","volume":"2018","author":"MR Glineburg","year":"1693","unstructured":"Glineburg MR, Todd PK, Charlet-Berguerand N, Sellier S. Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in fragile X tremor ataxia syndrome. Brain Res. 1693;2018:43\u201354.","journal-title":"Brain Res"},{"key":"1774_CR13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s40478-019-0796-1","volume":"7","author":"L Ma","year":"2019","unstructured":"Ma L, Herren AW, Espinal G, Randol J, McLaughlin B, et al. Composition of intranuclear inclusions of fragile X-associated tremor\/ataxia syndrome. Acta Neuropathol Commun. 2019;7:143.","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"1774_CR14","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1074\/jbc.R800025200","volume":"284","author":"JR O\u2019Rourke","year":"2009","unstructured":"O\u2019Rourke JR, Swanson MS. Mechanisms of RNA-mediated disease. J Biol Chem. 2009;284(12):7419\u201323.","journal-title":"J Biol Chem"},{"issue":"23","key":"1774_CR15","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1093\/hmg\/ddi394","volume":"14","author":"DG Arocena","year":"2005","unstructured":"Arocena DG, Iwahashi CK, Won N, Beilina A, Ludwig AL, et al. Induction of inclusion formation and disruption of lamin A\/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet. 2005;14(23):3661\u201371.","journal-title":"Hum Mol Genet"},{"key":"1774_CR16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00709-015-0861-y","volume":"253","author":"M Dubinska-Magiera","year":"2016","unstructured":"Dubinska-Magiera M, Chmielewska M, Koziol K, Machowska M, Hutchison CJ, et al. Xenopus LAP2\u03b2 protein knockdown affects location of lamin B and nucleoporins and has effect on assembly of cell nucleus and cell viability. Protoplasma. 2016;253:943\u201356.","journal-title":"Protoplasma"},{"key":"1774_CR17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2006.09.004","volume":"87","author":"MD Wittenberger","year":"2007","unstructured":"Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Weit CK, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87:456\u201365.","journal-title":"Fertil Steril"},{"key":"1774_CR18","doi-asserted-by":"crossref","unstructured":"Martin JR, Arici A. Fragile X and reproduction. Curr Opin Obstet Gynecol. 2008;20:216\u201320.","DOI":"10.1097\/GCO.0b013e3282fe7254"},{"issue":"10","key":"1774_CR19","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/deq203","volume":"25","author":"A Tsafrir","year":"2010","unstructured":"Tsafrir A, Altarescu G, Margalioth E, Brooks B, Renbaum P, et al. PGD for fragile X syndrome: ovarian function is the main determinant of success. Hum Reprod. 2010;25(10):2619\u201336.","journal-title":"Hum Reprod"},{"key":"1774_CR20","doi-asserted-by":"crossref","unstructured":"Man L, Lekovich J, Rosenwaks Z, Gerhardt J. Fragile X-associated diminished ovarian reserve and primary ovarian insufficiency from molecular mechanisms to clinical manifestations. Front Mol Neurosci. 2017;10:290.","DOI":"10.3389\/fnmol.2017.00290"},{"key":"1774_CR21","doi-asserted-by":"crossref","unstructured":"Fink DA, Nelson LM, Pyeritz R, Johnson J, Sherman SL. Fragile X associated primary ovarian insufficiency (FXPOI): case report and literature review. Front Genet 2018; 9:article 529.","DOI":"10.3389\/fgene.2018.00529"},{"issue":"6","key":"1774_CR22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1369\/0022155412441002","volume":"60","author":"GE Hoffman","year":"2012","unstructured":"Hoffman GE, Le WW, Entezam A, Otsuka N, Tong ZB, et al. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem. 2012;60(6):439\u201356.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"1774_CR23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/humrep\/dev280","volume":"31","author":"RAM Buijsen","year":"2016","unstructured":"Buijsen RAM, Visser JA, Kramer P, Severijnen EAWFM, Gearing M, et al. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency. Hum Reprod. 2016;31(1):158\u201368.","journal-title":"Hum Reprod"},{"issue":"23","key":"1774_CR24","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1093\/hmg\/dds348","volume":"21","author":"C Lu","year":"2012","unstructured":"Lu C, Lin L, Tan H, Wu H, Sherman SL, et al. Fragile X permutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum Mol Genet. 2012;21(23):5039\u201347.","journal-title":"Hum Mol Genet"},{"key":"1774_CR25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/oxfordjournals.aje.a009609","volume":"148","author":"A Morabia","year":"1998","unstructured":"Morabia A, Costanza MC, World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. International variability in ages at menarche, first livebirth, and menopause. Am J Epidemiol. 1998;148:1195\u2013205.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1774_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0015-0282(97)81482-3","volume":"68","author":"PAH Van Noord","year":"1997","unstructured":"Van Noord PAH, Boersma H, Dubas JS, Te Velde E, Dorland M. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril. 1997;68(1):95\u2013102.","journal-title":"Fertil Steril"},{"issue":"4","key":"1774_CR27","first-page":"604","volume":"67","author":"CB Coulam","year":"1986","unstructured":"Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604\u20136.","journal-title":"Obstet Gynecol"},{"key":"1774_CR28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ejhg.5200451","volume":"8","author":"A Murray","year":"2000","unstructured":"Murray A, Ennis S, MacSwiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet. 2000;8:247\u201352.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"1774_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0031-1280915","volume":"29","author":"SD Sullivan","year":"2011","unstructured":"Sullivan SD, Weit C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011;29(4):299\u2013307.","journal-title":"Semin Reprod Med"},{"issue":"2","key":"1774_CR30","first-page":"45","volume":"50","author":"NE Avis","year":"1995","unstructured":"Avis NE, McKinley SM. The Massachusetts women\u2019s health study: an epidemiological investigation of the menopause. JAMWA. 1995;50(2):45\u201351.","journal-title":"JAMWA"},{"issue":"2","key":"1774_CR31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00042192-200007020-00005","volume":"7","author":"SL Crawford","year":"2000","unstructured":"Crawford SL, Casey VA, Avis NE, McKinlay SM. A longitudinal study of weight and the menopause transition: results from the Massachusetts women\u2019s health study. Menopause. 2000;7(2):96\u2013104.","journal-title":"Menopause"},{"issue":"1","key":"1774_CR32","doi-asserted-by":"crossref","first-page":"e8772","DOI":"10.1371\/journal.pone.0008772","volume":"5","author":"WHB Wallace","year":"2010","unstructured":"Wallace WHB, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;5(1):e8772.","journal-title":"PLoS One"},{"key":"1774_CR33","doi-asserted-by":"crossref","first-page":"E845","DOI":"10.1210\/jc.2015-1298","volume":"100","author":"M Depmann","year":"2015","unstructured":"Depmann M, Faddy MJ, van der Schouw YT, Peeters PHM, Kelsey TW, et al. The relationship between variation in size of the primordial follicle pool and age at natural menopause. J Clin Endocrinol Metab. 2015;100:E845\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1774_CR34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/humrep\/dem408","volume":"23","author":"KR Hansen","year":"2008","unstructured":"Hansen KR, Knowlton NS, Thyer AC, Charleston JS. Soules, et al. A new model of reproductive aging: the decline in non-growing follicle number from birth to menopause. Hum Reprod. 2008;23(4):699\u2013707.","journal-title":"Hum Reprod"},{"key":"1774_CR35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1866-1955-6-26","volume":"6","author":"SL Sherman","year":"2014","unstructured":"Sherman SL, Curnow EC, Easley CA, Hukema RK, Tejada MI, et al. Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI). J Neurodev Disord. 2014;6:26.","journal-title":"J Neurodev Disord"},{"issue":"6","key":"1774_CR36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/molehr\/gaw023","volume":"22","author":"CC Dioguardi","year":"2016","unstructured":"Dioguardi CC, Uslu B, Haynes M, Kurus M, Gul M, et al. Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency. Mol Hum Reprod. 2016;22(6):384\u201396.","journal-title":"Mol Hum Reprod"},{"issue":"5","key":"1774_CR37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1210\/jcem-49-6-851","volume":"49","author":"KP McNatty","year":"1979","unstructured":"McNatty KP, Smith DM, Makris A, Osathanondh R, Ryan KJ. The microenvironment of the human antral follicle: interrelationships among steroid levels in antral follicles, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab. 1979;49(5):851\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1774_CR38","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/humrep\/der146","volume":"26","author":"MA Spath","year":"2011","unstructured":"Spath MA, Feuth TB, Allen EG, Smits APT, Yntema HG, et al. Intra-individual stability over time of standardized anti-M\u00fcllerian hormone in FMR1 premutation carriers. Hum Reprod. 2011;26(8):2185\u201391.","journal-title":"Hum Reprod"},{"issue":"5","key":"1774_CR39","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/humrep\/den050","volume":"23","author":"J Rohr","year":"2008","unstructured":"Rohr J, Allen EG, Charen K, Giles J, He W, et al. Anti-M\u00fcllerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod. 2008;23(5):1220\u20135.","journal-title":"Hum Reprod"},{"issue":"1","key":"1774_CR40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5653\/cerm.2012.39.1.10","volume":"39","author":"JY Kim","year":"2012","unstructured":"Kim JY. Control of ovarian primal follicle activation. Clin Exp Reprod Med. 2012;39(1):10\u20134.","journal-title":"Clin Exp Reprod Med"},{"key":"1774_CR41","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-16-0522","volume":"233","author":"MW Pankhurst","year":"2017","unstructured":"Pankhurst MW. A putative role for anti-M\u00fcllerian hormone (AMH) in optimizing ovarian reserve expenditure. J Endocrinol. 2017;233:R1\u2013R13.","journal-title":"J Endocrinol"},{"issue":"3","key":"1774_CR42","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","volume":"143","author":"ALL Durlinger","year":"2002","unstructured":"Durlinger ALL, Gruijters MJG, Kramer P, Karels B, Ingraham HA, et al. Anti-M\u00fcllerian hormone inhibits initiation of primordial follicle growth the mouse ovary. Endocrinol. 2002;143(3):1076\u201384.","journal-title":"Endocrinol"},{"issue":"9","key":"1774_CR43","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/del165","volume":"21","author":"IB Carlsson","year":"2006","unstructured":"Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen APN, Hovatta O. Anti-M\u00fcllerian hormone inhibits initiation of growth of human primordial follicles in vitro. Hum Reprod. 2006;21(9):2223\u20137.","journal-title":"Hum Reprod"},{"key":"1774_CR44","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","volume":"140","author":"ALL Durlinger","year":"1999","unstructured":"Durlinger ALL, Kramer P, Karels B, De Jong FH, Uilenbroek JTJ, et al. Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary. Endocrinol. 1999;140:5789\u201396.","journal-title":"Endocrinol"},{"issue":"1","key":"1774_CR45","first-page":"1","volume":"3","author":"L Leonte","year":"2007","unstructured":"Leonte L, Coculescu M, Radian S, Fica S, Caragheorgheopol A, et al. Anti-M\u00fcllerian hormone (AMH) as a useful marker in diagnosis of polycystic ovary syndrome. Acta Endocrinol. 2007;3(1):1\u201311.","journal-title":"Acta Endocrinol"},{"key":"1774_CR46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1530\/ror.0.0010162","volume":"1","author":"JL Tilly","year":"1996","unstructured":"Tilly JL. Apoptosis and ovarian function. Rev Reprod. 1996;1:162\u201372.","journal-title":"Rev Reprod"},{"issue":"4","key":"1774_CR47","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/endo.137.4.8625923","volume":"137","author":"SY Chun","year":"1996","unstructured":"Chun SY, Eisenhauer KM, Billig H, Perlas E, Hsueh AJ. Hormonal regulation of apoptosis in early antral follicles: follicle-stimulations hormone as a major survival factor. Endocrinol. 1996;137(4):1447\u201356.","journal-title":"Endocrinol"},{"key":"1774_CR48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/rep.0.1230023","volume":"123","author":"E Markstr\u00f6m","year":"2002","unstructured":"Markstr\u00f6m E, Svensson EC, Shah R, Svanberg B, Billig H. Survival factors regulating ovarian apoptosis-dependence on follicle differentiation. Reprod. 2002;123:23\u201330.","journal-title":"Reprod"},{"key":"1774_CR49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1757-2215-2-9","volume":"2","author":"M Orisaka","year":"2009","unstructured":"Orisaka M, Tajima K, Tsang BK, Kotsuji F. Oocyte-granulosa-theca cell interactions during preantral follicular development. J Ovarian Res. 2009;2:9.","journal-title":"J Ovarian Res"},{"issue":"4","key":"1774_CR50","first-page":"853","volume":"99","author":"L Meng","year":"2018","unstructured":"Meng L, Jan SZ, Hamer G, van Pelt AM, van der Stelt I, et al. Preantral follicular atresia occurs mainly through autophagy, while antral follicles degenerate mostly through apoptosis. Biol Reprod. 2018;99(4):853\u201363.","journal-title":"Biol Reprod"},{"key":"1774_CR51","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1262\/jrd.18069","volume":"53","author":"F Matsuda-Minehata","year":"2006","unstructured":"Matsuda-Minehata F, Inoue N, Goto Y, Manabe N. The regulation of ovarian granulose cell death by pro- and anti-apoptotic molecules. J Reprod Dev. 2006;53:695\u2013705.","journal-title":"J Reprod Dev"},{"key":"1774_CR52","first-page":"55","volume":"64","author":"KP McNatty","year":"2007","unstructured":"McNatty KP, Reader K, Smith P, Heath DA, Jungle JL. Control of ovarian follicular development to the gonadotropin-dependent phase: a 2006 perspective. Soc Reprod Fertil Suppl. 2007;64:55\u201368.","journal-title":"Soc Reprod Fertil Suppl"},{"issue":"2","key":"1774_CR53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"Weenen C, Laven JSE, von Bergh ARM, Cranfield M, Groome NP, et al. Anti-M\u00fcllerian hormone expression pattern in human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):76\u201383.","journal-title":"Mol Hum Reprod"},{"issue":"2","key":"1774_CR54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","volume":"17","author":"A Gougeon","year":"1996","unstructured":"Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17(2):121\u201355.","journal-title":"Endocr Rev"},{"key":"1774_CR55","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1095\/biolreprod61.2.358","volume":"61","author":"TC Lavranos","year":"1999","unstructured":"Lavranos TC, Mathis JM, Latham SE, Kalionis B, Shay JW, Rodgers RJ. Evidence for ovarian granulosa stem cells: telomerase activity and localization of the telomerase ribonucleic acid component in bovine ovarian follicles. Biol Reprod. 1999;61:338\u201366.","journal-title":"Biol Reprod"},{"key":"1774_CR56","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1530\/rep.0.1260415","volume":"126","author":"RJ Rodgers","year":"2003","unstructured":"Rodgers RJ, Irving-Rodgers HF, Russell DL. Extracellular matrix of the developing ovarian follicle. Reprod. 2003;126:415\u201324.","journal-title":"Reprod"},{"key":"1774_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2017-00164","volume":"39","author":"JS Richards","year":"2018","unstructured":"Richards JS, Ren YA, Candelaria N, Adams JE, Rajkovic A. Ovarian follicular theca cell recruitment, differentiation, and impact on fertility: 2017 update. Endocr Rev. 2018;39:1\u201320.","journal-title":"Endocr Rev"},{"issue":"5","key":"1774_CR58","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1210\/endo.133.5.8404672","volume":"133","author":"H Billig","year":"1993","unstructured":"Billig H, Furuta I, Hsueh AJW. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinol. 1993;133(5):2204\u201312.","journal-title":"Endocrinol"},{"issue":"2","key":"1774_CR59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1933719107312037","volume":"15","author":"A Yaba","year":"2008","unstructured":"Yaba A, Bianchi V, Borini A, Johnson J. A putative mitotic checkpoint on mTOR function controls cell proliferation and survival in ovarian granulosa cells. Reprod Sci. 2008;15(2):128\u201338.","journal-title":"Reprod Sci"},{"issue":"7","key":"1774_CR60","doi-asserted-by":"crossref","first-page":"e21415","DOI":"10.1371\/journal.pone.0021415","volume":"6","author":"J Yu","year":"2011","unstructured":"Yu J, Yaba A, Kas\u0131man C, Thompson T, Johnson J. mTOR controls ovarian follicle growth by regulating granulosa cell proliferation. PLoS One. 2011;6(7):e21415.","journal-title":"PLoS One"},{"issue":"8","key":"1774_CR61","doi-asserted-by":"crossref","first-page":"e105121","DOI":"10.1371\/journal.pone.0105121","volume":"9","author":"SE Elizur","year":"2014","unstructured":"Elizur SE, Lebovitz O, Derech-Halm S, Dratviman-Storobinsky O, Feldman B, et al. Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers. PLoS One. 2014;9(8):e105121.","journal-title":"PLoS One"},{"issue":"8","key":"1774_CR62","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/humrep\/dem148","volume":"22","author":"EG Allen","year":"2007","unstructured":"Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22(8):2142\u201352.","journal-title":"Hum Reprod"},{"issue":"5","key":"1774_CR63","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2559.2011.03959.x","volume":"59","author":"MC Chang","year":"2011","unstructured":"Chang MC, DeCaro JJ, Zheng M, Gearing M, Shubeck L, et al. Ovarian histopathology and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls. Histopathology. 2011;59(5):1018\u201323.","journal-title":"Histopathology"},{"key":"1774_CR64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/REP-10-0094","volume":"140","author":"JM Young","year":"2010","unstructured":"Young JM, McNeilly AS. Theca: the forgotten cell of the ovarian follicle. Reprod. 2010;140:489\u2013504.","journal-title":"Reprod"},{"key":"1774_CR65","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1242\/dev.060426","volume":"139","author":"KK Niakan","year":"2012","unstructured":"Niakan KK, Han J, Pederson PA, Simon C, Reijo Pera RA. Human pre-implantation embryo development. Development. 2012;139:829\u201341.","journal-title":"Development"},{"key":"1774_CR66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1743-1050-3-2","volume":"3","author":"J Griffin","year":"2006","unstructured":"Griffin J, Emery BR, Huang I, Peterson CM, Carrell DT. Comparative analysis of follicle morphology and oocyte diameter in four mammalian species (mouse, hamster, pig, and human). J Exp Clin Assist Reprod. 2006;3:2.","journal-title":"J Exp Clin Assist Reprod"},{"key":"1774_CR67","unstructured":"Williams CJ, Erickson GF. Morphology and physiology of the ovary. [Updated 2012 Jan 30]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000\u20132020. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK278951\/."},{"issue":"9","key":"1774_CR68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/pd.2179","volume":"29","author":"A Reches","year":"2009","unstructured":"Reches A, Malcov M, Ben-Yosef D, Azem F, Amit A, Yaron Y. Preimplantation genetic diagnosis for fragile X syndrome: is there increased transmission of abnormal FMR1 alleles among female heterozygotes? Prenat Diagn. 2009;29(9):57\u201361.","journal-title":"Prenat Diagn"},{"key":"1774_CR69","doi-asserted-by":"crossref","unstructured":"Platteau P, Sermon K, Seneca S, Van Steirteghem A, Devroe P, et al. Preimplantation genetic diagnosis for fragile X syndrome: difficult but not impossible. Hum Reprod. 2002;17(11):2807\u201312.","DOI":"10.1093\/humrep\/17.11.2807"},{"issue":"7","key":"1774_CR70","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/humrep\/dex090","volume":"32","author":"S Avraham","year":"2017","unstructured":"Avraham S, Almog B, Reches A, Zakar L, Malcov M, et al. The ovarian response in fragile X patients and permutations carriers undergoing IVF-PGD: reappraisal. Hum Reprod. 2017;32(7):1508\u201311.","journal-title":"Hum Reprod"},{"key":"1774_CR71","first-page":"3019","volume":"82","author":"PG Van Deerlin","year":"1997","unstructured":"Van Deerlin PG, Cekleniak N, Coutifaris C, Boyd J, Strauss JF. Evidence for the oligoclonal origin of the granulosa cell population of the mature human follicle. J Clin Endocrinol Metab. 1997;82:3019\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"1774_CR72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/ror.0.0030183","volume":"3","author":"JA Elvin","year":"1998","unstructured":"Elvin JA, Matzuk MM. Mouse models of ovarian failure. Rev Reprod. 1998;3:183\u201395.","journal-title":"Rev Reprod"},{"issue":"2","key":"1774_CR73","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/humrep\/deh635","volume":"20","author":"AK Sullivan","year":"2004","unstructured":"Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2004;20(2):402\u201312.","journal-title":"Hum Reprod"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01774-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-020-01774-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-020-01774-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:49:06Z","timestamp":1620262146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-020-01774-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1007\/s10815-020-01774-x","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"10 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}